KRTX - Karuna Therapeutics gains as HSR waiting period for Bristol-Myers deal expires
2024-03-14 07:44:57 ET
More on Karuna Therapeutics
- Bronte Capital - Karuna Therapeutics: A Rare Mistake With A Natural Test Of Process
- Karuna Therapeutics: Getting Sold Short
- Karuna Therapeutics drops on no apparent news amid deal with Bristol-Myers Squibb
- M&A activity expected to pick up in 2024, bankers say
- Seeking Alpha’s Quant Rating on Karuna Therapeutics